HILLSIDE, N.J., July 11, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that the team comprising its subsidiary and its contract development partner, Fraunhofer USA Center for Molecular Biotechnology (“FCMB”), was awarded a contract from the U.S. Department of Defense through the Defense Advanced Research Projects Agency (“DARPA”) to further develop and validate the team’s novel system for accelerated manufacturing of biopharmaceuticals. The total value of the contract, if all phases of the development program are completed, would be $8.5 million.
